Keyphrases
High Performance Liquid Chromatography-tandem Mass Spectrometry (HPLC-MS/MS)
100%
Bile Acids
100%
Diabetes
100%
Metabolic Profiling
100%
Diabetic Patients
100%
Amino Acids
100%
Pre-diabetes (pre-DM)
50%
High-throughput Analysis
50%
Analytical Method
50%
Antihypertensive Medication
50%
Glycemic Control
50%
Method Performance
50%
Limit of Detection
50%
Metabolite Concentrations
50%
Human Plasma
50%
Limit of Quantification
50%
Sampling Time
50%
Quantitative Methods
50%
Laboratory Setting
50%
Sample Preparation
50%
Statin Drugs
50%
Clinically Significant
50%
Lipid Biomarkers
50%
Metabolic Biomarkers
50%
Microalbuminuria
50%
Repeatability
50%
MS Method
50%
Clinical Measurement
50%
Type 1 Diabetes Patients
50%
Kidney Disease
50%
Comorbidity
50%
Diabetes Clinic
50%
Plasma Metabolites
50%
Clinical Laboratory
50%
Neuroscience
Bile Acid
100%
Diabetes Mellitus
100%
Amino Acid
100%
Blood Plasma
100%
Statin
50%
Antihypertensive Agent
50%
Liquid Chromatography-Mass Spectrometry
50%
Comorbidity
50%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Diabetes Mellitus
100%
Bile Acid
66%
Amino Acid
66%
Statin (Protein)
33%
Antihypertensive Agent
33%
Macroalbuminuria
33%
Insulin Dependent Diabetes Mellitus
33%
Comorbidity
33%
Ultra High Performance Liquid Chromatography
33%
Cohort Study
33%
Impaired Glucose Tolerance
33%
Biochemistry, Genetics and Molecular Biology
Metabolite
100%
Bile Acid
33%
Blood Plasma
33%
Amino Acid
33%
Comorbidity
16%
Quantitative Technique
16%
Statin
16%
Lipid
16%
Cohort Study
16%
Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry
16%
Impaired Glucose Tolerance
16%
Small Molecule
16%
Glycemic Control
16%
Chemistry
Bile Acid
33%
Antihypertensive
16%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
16%
Antihypertensive Agent
16%
Immunology and Microbiology
Ultra High Performance Liquid Chromatography-Tandem Mass Spectrometry
16%